Logos Global Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001792126

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2025 · 56 positions · Total reported value $949.89M · Top-10 concentration 41.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 25 new · 19 cut · 20 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +22.9% · vs SPY +8.1% · Prev Value $1.89B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, Logos Global Management LP disclosed 56 equity positions with a combined reported value of $949.89M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were AKRO ($56.98M), ARVN ($47.50M), RVMD ($46.70M). By sector, the heaviest allocations are Health Care 81.7%, Other 18.3%. Versus the prior quarter, allocation shifted toward Health Care (+6.2pp) and away from Other (-6.2pp).

Versus the prior quarter, Logos Global Management LP opened 25 new positions, trimmed 19 and fully exited 20, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 48% of names.

The largest new positions opened in Q3 2025 were ABVX ($35.23M), PCVX ($22.51M), PTGX ($19.93M).

Of the 20 positions fully exited versus the prior quarter, the largest were XBI ($82.93M), TEVA ($25.14M), UTHR ($24.42M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • ABVX ABIVAX SA · $35.23M
  • PCVX VAXCYTE INC · $22.51M
  • PTGX PROTAGONIST THERAPEUTICS INC · $19.93M
  • AMLX AMYLYX PHARMACEUTICALS INC · $19.71M
  • LBRX LB PHARMACEUTICALS INC · $17.84M
  • QURE UNIQURE NV · $17.51M
  • KYMR KYMERA THERAPEUTICS INC · $14.15M
  • ACLX ARCELLX INC · $13.55M

Fully Exited (vs previous quarter)

  • XBI SPDR SERIES TRUST · prev qtr: $82.93M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · prev qtr: $25.14M
  • UTHR UNITED THERAPEUTICS CORP DEL · prev qtr: $24.42M
  • NBIX NEUROCRINE BIOSCIENCES INC · prev qtr: $18.85M
  • MDGL MADRIGAL PHARMACEUTICALS INC · prev qtr: $15.13M
  • KRYS KRYSTAL BIOTECH INC · prev qtr: $13.75M
  • CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $12.21M · history
  • BHVN BIOHAVEN LTD · prev qtr: $9.88M

Insider Transactions (Form 4)

Latest Logos Global Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Logos Global Management LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 68 US equity positions with a combined value of $2.32B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-117248 (status: Approved), registered 2019-08-26
  • Regulatory AUM (Form ADV): $2.25B as of 2026-04-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 1 hedge funds

Portfolio Structure

  • 68 positions · $2.32B reported value (Q2 2026)
  • Top 10 holdings = 48.3% of reported value
  • Largest position: ERAS (ERASCA INC COM) at 9.6%
  • Average position size: $34.16M

Sector Tilt

  • Health Care 99.1%
  • Financials 0.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 18 added, 19 reduced, 20 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.7%
Other 18.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.20M $56.98M 6.00%
6.00%
Hold
2 5.58M $47.50M 5.00%
5.00%
Add
3 1.00M $46.70M 4.92%
4.92%
Reduce
4 3.25M $37.99M 4.00%
4.00%
Add
5 375.00K $35.91M 3.78%
3.78%
Add
6 4.05M $35.76M 3.77%
3.77%
Add
7 415.00K $35.23M 3.71%
3.71%
New
8 15.15M $33.03M 3.48%
3.48%
Add
9 1.23M $31.82M 3.35%
3.35%
Add
10 3.21M $31.41M 3.31%
3.31%
Hold
11 850.00K $30.88M 3.25%
3.25%
Add
12 2.40M $30.36M 3.20%
3.20%
Add
13 450.00K $29.74M 3.13%
3.13%
Reduce
14 3.65M $27.52M 2.90%
2.90%
Reduce
15 200.00K $26.36M 2.77%
2.77%
Reduce
16 600.00K $26.14M 2.75%
2.75%
Reduce
17 850.00K $23.80M 2.51%
2.51%
Hold
18 1.00M $22.63M 2.38%
2.38%
Hold
19 625.00K $22.51M 2.37%
2.37%
New
20 200.00K $20.20M 2.13%
2.13%
Add
21 2.20M $20.13M 2.12%
2.12%
Add
22 300.00K $19.93M 2.10%
2.10%
New
23 1.45M $19.71M 2.08%
2.08%
New
24 1.13M $17.84M 1.88%
1.88%
New
25 300.00K $17.51M 1.84%
1.84%
New
26 250.00K $14.15M 1.49%
1.49%
New
27 100.00K $14.01M 1.48%
1.48%
Reduce
28 165.00K $13.55M 1.43%
1.43%
New
29 850.00K $13.45M 1.42%
1.42%
Reduce
30 525.00K $12.73M 1.34%
1.34%
New
31 450.00K $12.24M 1.29%
1.29%
Reduce
32 500.00K $12.22M 1.29%
1.29%
Hold
33 2.50M $8.07M 0.85%
0.85%
Hold
34 950.00K $7.98M 0.84%
0.84%
New
35 200.00K $7.87M 0.83%
0.83%
New
36 500.00K $7.18M 0.76%
0.76%
New
37 2.05M $7.17M 0.76%
0.76%
New
38 600.00K $7.13M 0.75%
0.75%
Add
39 340.00K $6.96M 0.73%
0.73%
Reduce
40 950.00K $6.65M 0.70%
0.70%
New
41 125.00K $6.62M 0.70%
0.70%
Reduce
42 175.00K $6.52M 0.69%
0.69%
New
43 625.00K $5.39M 0.57%
0.57%
Hold
44 900.00K $5.31M 0.56%
0.56%
New
45 275.00K $4.43M 0.47%
0.47%
Hold
46 150.00K $3.74M 0.39%
0.39%
New
47 500.00K $3.64M 0.38%
0.38%
Reduce
48 750.00K $3.46M 0.36%
0.36%
New
49 1.50M $2.85M 0.30%
0.30%
Reduce
50 473.56K $2.06M 0.22%
0.22%
Hold

FAQ

What did Logos Global Management LP buy in 2025-Q3?

In its 2025-Q3 13F filing, Logos Global Management LP reported 56 equity positions worth $949.89M in aggregate; its largest disclosed positions were AKRO ($56.98M), ARVN ($47.50M), RVMD ($46.70M).

How large is Logos Global Management LP's portfolio?

Logos Global Management LP reported $949.89M of long equity holdings across 56 positions as of 2025-Q3. Top-10 holdings account for 41.3% of reported value.

What is Logos Global Management LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/logos-global-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →